CS Paper Radar

HybridDualPathNet: Cross-Fusion Attention of EfficientNetV2 and Swin Transformer for Brain MRI Classification of Alzheimer's and Parkinson's Disease

Jarpula Nirjala, Rahul Patel

cs.CV cs.LGcs.SE ·submitted 2026-10-12 18:13 UTC · v1

Abstract

Separating Alzheimer's Disease (AD), Parkinson's Disease (PD), and Healthy Controls (HC) using structural MRI remains challenging because disease signatures overlap and model performance can be strongly affected by data partitioning. We present HybridDualPathNet, a hybrid architecture combining EfficientNetV2-S for local features and Swin-Tiny for global context through a Cross-Fusion Attention (CFA) module. We evaluate the model in two experiments. First, on the Kaggle APD-3-Class dataset using an image-level split, the model achieves 98.25% accuracy. Second, on a combined Kaggle and Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset containing 17,859 slices, we use a per-source split with patient-wise separation for ADNI subjects. In this setting, the model achieves 73.37% standard accuracy and a macro AUC of 0.880. Source-stratified evaluation reveals a substantial domain gap, with 91.2% accuracy on Kaggle test images and 59.2% on ADNI test images. Temperature scaling reduces expected calibration error from 0.130 to 0.015, while split-conformal prediction achieves 89.5% coverage. Saliency analyses using Grad-CAM++, Integrated Gradients, and occlusion indicate that model activations concentrate on brain tissue. These results highlight the importance of patient-level separation, cross-dataset evaluation, and uncertainty estimation when assessing MRI classification systems. The findings also show that strong performance on a single dataset does not necessarily translate to reliable generalization across imaging cohorts.

Comment
Two experimental settings: Kaggle-only image-level evaluation and combined Kaggle and ADNI evaluation with patient-wise separation for ADNI subjects

Closest papers

Nearest neighbours by meaning across the whole index.

Evidence Before Accuracy: A MRI-PET Fusion Network for Alzheimer Disease Classification with Causal Regional Validation

cs.CV ·2026-09-28 ·Saeid Firouzi Daghigh, Saeed Ayat
similarity 0.72
Abstract

Deep learning models for Alzheimer disease (AD) classification routinely report near-perfect discrimination, yet few are shown to rest on AD-relevant neurobiology rather than on dataset artifacts, subject-level leakage, or non-brain image content. We present a fusion network combining T1 MRI and FDG PET across axial, coronal, and sagittal planes, trained on ADNI consists of 554 paired subjects. The fusion model reaches AUC 0.962, accuracy 0.909, and F1 0.891, competitive with recent 3D CNN and multimodal transformer systems at substantially lower cost. We first quantify how much modality, plane and slice geometry matter. A validation-only search over slice centres and neighbour spacings moves AUC by 0.180 for MRI and 0.078 for PET, selecting narrow spacing for MRI and wide spacing for PET, with the chosen coronal centres falling on the hippocampal body and on the posterior cingulate respectively. The contribution, however, is the evidence layer built around that number. Shortcut controls collapse the model to AUC 0.622 (silhouette), 0.608 (exterior), and 0.500 (blank), and a label-permutation null yields 0.456. Forward region-of-interest (ROI) ablation shows that masking medial temporal cortex in MRI and the posterior default-mode network (DMN) in PET produces the largest shift in the AD logit, while area-matched controls remain indistinguishable from that null. Reverse ROI ablation shows that the medial temporal lobe alone retains 89.2% of above-chance discrimination in MRI and the posterior DMN alone retains 79.0% in PET. A quantitative comparison of attribution methods shows occlusion sensitivity reaching 3.5-5.0* enrichment inside a priori AD regions against 0.10-0.43* in controls. Ablation and attribution independently establish a biologically correct double dissociation: hippocampal evidence is carried by MRI, posterior cingulate evidence by PET.

0.12

How Robust Are CNNs and Vision Transformers for Alzheimer's MRI Classification Across Datasets?

cs.CV ·2026-10-24 ·Hafija Aktar, Molly Croes, Frank S. Menniti, Abdeltawab Hendawi
dataset similarity 0.69
Abstract · 12 pages, 9 tables, 3 figures. Submitted to Biomedical Signal Processing and Control

Accurate assessment of Alzheimer's disease stages from MRI is important for understanding disease progression and supporting the development of computer-aided analysis tools. Deep learning models have shown promising results for Alzheimer's disease classification from MRI. However, when evaluated on single datasets, it is difficult to determine whether the observed performance reflects consistent architectural behavior or dataset-specific effects. In this work, we present a multi-dataset benchmarking framework with standardized preprocessing and evaluation. We compare five architectures: ResNet-50, ReXNet-150, Swin Transformer, ViT-Base, and ViT-Large. The models are evaluated across three MRI datasets representing severe class imbalance, train-test distribution mismatch, and large-scale augmentation. The results show broadly consistent performance patterns across datasets, with ViT-Large achieving the best performance on all three datasets and reaching up to 99.84% accuracy and 99.86% macro F1. Performance differences between architectures are most pronounced under distribution mismatch and considerably smaller in the augmented-data setting. Across datasets, lower class-level performance is observed primarily among adjacent early-stage categories, particularly Very Mild and Mild impairment. These findings highlight the importance of evaluating deep learning architectures across multiple data conditions rather than relying on single-dataset performance.

0.20

Anatomical Grounding and Leakage-Aware Multimodal Contrastive Learning for Alzheimer's Disease Classification from Structural MRI

cs.CV cs.AI ·2026-09-14 ·Paul-Gabriel Nicolae, Irina Georgiana Mocanu
theory similarity 0.69
Abstract · 13 pages, 4 figures

Deep networks trained on structural MRI for Alzheimer's disease (AD) staging often reach reasonable accuracy while attending to anatomically irrelevant regions, and multimodal models that add clinical tables frequently rely on variables that were used to assign the diagnostic label in the first place. We study both issues with a deliberately lightweight slice-based encoder (ResNet18 with a one-layer Transformer over slices) on 1,075 baseline T1-weighted scans from ADNI-1. First, we use FastSurfer segmentations as an anatomical reference: YOLOv8 models trained on segmentation-derived labels localize Alzheimer-relevant structures with mAP_50 above 0.96, and a Grad-CAM comparison shows that the image-only classifier frequently attends to the skull, orbits and background. Second, we adapt a CLIP-style image - tabular contrastive framework and organize ADNIMERGE variables along a label-leakage spectrum. Fusion with cognitive scores yields 87.3% three-way accuracy, which we treat as a leakage-driven upper bound rather than an imaging result; fusion with regional volumes yields 73.0%. We observe that the choice of contrastive target changes what the image encoder learns: on MCI vs. CN, the image-only head reaches 52.4% when the encoder is aligned to cognitive scores and 73.8\% when aligned to volumes, although no tabular input is used at inference. Third, restricting the input to a per-subject crop of the medial temporal lobe raises image-only three-way accuracy from 58.7% to 65.1%. All results come from single runs on a small balanced test set, and we report confidence intervals and the protocol differences that prevent direct comparison with published numbers.

0.16

A Multimodal Explainable Deep Learning Framework for Alzheimer's Disease Diagnosis using 3D Magnetic Resonance Imaging and Clinical Data

cs.CV stat.ML ·2026-09-11 ·Yusuf Brima, Marcellin Atemkeng, Lakshmana Rao Namamula, Antoine Vacavant
similarity 0.67
Abstract

Dementia is a major and growing global health burden, with Alzheimer's disease (AD) accounting for most cases. Timely and accurate diagnosis is central to managing this burden and increasingly depends on integrating complementary clinical and imaging information. Multimodal deep learning can combine these modalities for AD diagnosis, but how its explanations behave across modalities, fusion strategies, and cohorts remains unclear. We developed an explainable multimodal framework pairing a 3D CNN encoder for T1-weighted MRI with a feedforward network for harmonized clinical and demographic data, comparing varied model setups on three-way and pairwise diagnostic tasks using 6,479 internal records from the ADNI and 1,703 independent records from the OASIS-3. On ADNI, the tabular-only model achieved the highest three-class AUC-ROC of 0.879 and best discriminated cognitively normal (CN) versus mild cognitive impairment (MCI; 0.903), while cross-attention performed best for MCI versus AD (0.861); CN versus AD was highly discriminative overall. On OASIS-3, the vision-only model performed best (three-class AUC-ROC 0.910); CN versus MCI remained difficult, and no fusion strategy consistently outperformed single modalities across tasks and cohorts. SHAP and Integrated Gradients identified the MMSE as the dominant tabular feature in both cohorts, with global feature rankings agreeing strongly in ADNI ($ρ=0.94$) and OASIS-3 ($ρ=0.96$); CAM-based explanations, however, changed with model configuration and cohort. These findings show that multimodal performance and explanations are task, modality, fusion, and cohort-dependent: a dominant cognitive signal persisted across cohorts, but feature contributions and CAM explanations did not, underscoring the need to evaluate explainability under cohort shift rather than as a stable, intrinsic property.

0.10

A comparison of CNN architectures for Alzheimer's disease detection in single-view MRI scans

eess.IV cs.CVcs.LG ·2026-08-12 ·Hiram Zuniga, Ulises Orozco-Rosas, Kenia Picos
publishedbenchmark similarity 0.66
Abstract · Accepted at SPIE Optics + Photonics 2026 for oral presentation. 14 pages, 7 figures, 8 tables

Alzheimer's disease is a leading cause of death with no cure. Therefore, early detection is critical to slow progression and preserve quality of life. Diagnosis relies on medical history, cognitive tests, physical exams, and MRI brain scans, making deep learning suitable for Alzheimer's classification. This work proposes a benchmark that evaluates ten different convolutional neural network (CNN) architectures (including ResNet, DenseNet, MobileNet, EfficientNet, and VGG family models) under the same held-out test split protocol. A two-stage transfer learning and full fine-tuning pipeline is introduced to perform training using a class-balanced subset (3,900 images) derived from the OASIS medical imaging dataset, comprising 86,437 single-view MRI brain scans labeled into four classifications of Alzheimer's disease: Non-Demented, Very Mild Dementia, Mild Dementia, and Moderate Dementia. The best results were achieved by VGG16, with a 0.9637 validation accuracy and a 0.9533 test accuracy score. A key finding documented in this work is the difficulty of classifying the transition from Non-Demented to Very Mild Demented stages, observed consistently across all ten architectures.

0.28

Evaluating the Generalization of Neuroimaging Foundation Models on African Brain MRI

cs.CV ·2026-09-21 ·Oluwatobi Iyanuoluwa Akinmuleya, Olatokun Shamsudeen Akano, Samuel Danquah Ankapong, Olamide Lawal, Toufiq Musah
published similarity 0.66
Abstract · MICCAI AFRICAI Workshop, Strasbourg, France, 2026, 10 Pages, 1 Figure, 2 Tables

Neuroimaging foundation models pretrained on large, predominantly western cohorts are increasingly proposed as general-purpose backbones for brain MRI analysis. Yet, their ability to generalize to underrepresented clinical populations remains largely untested. We evaluate four recent foundation models (BrainIAC, Neuro-JEPA, NeuroVFM, and Primus) on a three-way diagnostic classification task (Control, Dementia, Parkinson's disease) using a cohort of 88 subjects from a Nigerian clinical brain MRI dataset, across four modality configurations (T1w, T2w, T1w+T2w, FLAIR), and compare against an end-to-end trained ViT3D baseline. The frozen backbones collapse to majority-class predictions, while Neuro-JEPA on FLAIR shows modest but still limited discrimination. In contrast, the end-to-end trained ViT3D achieves higher accuracy and MCC on every task (up to 53.4% accuracy, MCC=0.27) and is the only model with non-trivial recall. Our findings suggest that these frozen neuroimaging foundation models are insufficient for fine-grained diagnostic classification in small, non-western clinical cohorts, motivating parameter-efficient adaptation and broader multi-site external validation for equitable deployment in global health settings.

0.29

A Generalizable Feature Extractor for Alzheimer's-Related Brain MRI Tasks

cs.CV q-bio.QM ·2026-09-04 ·Reza Rajabli, D. Louis Collins
similarity 0.65
Abstract · 26 pages (excluding the references section), 7 figures (excluding sub-figures)

When there is not enough labeled data to properly train deep learning models, transfer learning can help. We still do not fully understand how effective it is in neuroimaging, especially for Alzheimer's disease research. It is also not clear if these transferred models can work on new datasets without being retrained for each specific task. We evaluate whether a compact, supervised pretrained model can serve as a reusable foundation model for downstream neuroimaging tasks. We freeze the 7.18 million weights of a 3D CNN previously trained for brain-age prediction, and adapt it to each task using Low-Rank Adaptation (LoRA), requiring only ~1% additional trainable parameters. We evaluate generalizability in six experiments. Adapting the model to classify cognitively normal versus Dementia on ADNI gave an AUC of 0.964 on held-out folds (Experiment #1). Applying that adapted model unchanged to OASIS-3, with no retraining, gave an AUC of 0.871 (Experiment #2). Reusing its output logit together with age and a cognitive score distinguished stable from progressing MCI with an AUC of 0.828 (Experiment #3). Adapting the same backbone to predict amyloid positivity from structural MRI gave an AUC of 0.804 (Experiment #4). Finally, the same approach estimated ICV-normalized hippocampal and white matter hypointensity volumes directly from the T1w image, with R^2 of 0.80 and 0.91 respectively, tasks normally addressed with much larger U-Net networks (Experiments #5 and #6). A compact model supervised on brain age can therefore serve as a reusable backbone, adapting to each task with ~1% additional parameters and transferring to an unseen cohort without any training. Our findings suggest that a carefully trained brain age model can serve as an effective foundation model for Alzheimer's related tasks, even under strict data constraints.

0.18

Cross-disorder Learning of Imaging-derived Joint Mophometric Markers in Alzheimer's and Parkinson's Diseases

cs.LG q-bio.QMq-bio.NC ·2026-10-19 ·Yuji Zhao, Boris Gutman
code/datahot direction similarity 0.65
Abstract

As two most prevalent neurodegenerative diseases (NDDs), Alzheimer's disease (AD) and Parkinson's disease (PD) shared commonalities both in symptomology and pathophysiology. However, to what extent and in what way these two distinct disorders overlap remain underexplored. In this study, we propose an explicit, interpretable and spatially adaptive transfer learning framework to elucidate the morphometric biomarkers linked to AD and PD. We applied such high-dimensional machine learning model to two most popular open-source neuroimaging datasets, i.e., Alzheimer's Disease Neuroimaging Initiative (ADNI) and Parkinson's Progression Markers Initiative (PPMI). On the one hand, our cross-disorder classifier revealed neuro-anatomical alteration patterns well aligning with previous neuroimaging research findings and underscoring patients' clinical presentations. On the other hand, the spatially adaptive trained classifier using shared prior achieved statistically superior diagnostic performance compared to respective individual models, which further highlights the cross-disorder framework's efficacy on modeling limited-size datasets across disease domains.

0.37